CARLSBAD, Calif. - Aug. 2, 2022 - PRLog -- Universal Sequencing Technology Corporation (UST), announces today, August 2nd, 2022, that it has released "TELL-Seq Haplotype Phasing" App on Illumina Basespace™ Sequence Hub to further streamline and enable access to the TELL-Seq haplotype phasing workflow solution. This can effectively be used in broad research areas including... Learn More

CARLSBAD, Calif. - Oct. 24, 2022 - PRLog -- Universal Sequencing Technology Corporation (UST), a global leader in genomic sequencing innovations, announces today, October 24th, 2022, the release of 96-well plate TELL-Seq™ Library Multiplexing Primers for high throughput sample indexing. With this expanded indexing capability, our customers/TELL-seq users can pool many samples... Learn More

New solution to empower accurate interpretation of Next-Generation Sequencing data Expanded offerings to make personalized treatment options a reality in UAE and region Abu Dhabi, October 24, 2022: In a step aimed at boosting its clinical... Learn More

RESEARCH TRIANGLE PARK, NC – (October 17, 2022) – The PhenX Toolkit team will be at Booth 948 at the American Society of Human Genetics (ASHG) annual meeting in Los Angeles Oct. 26-28.  The Phenx Team will give demonstrations of how to use the Toolkit for biomedical research study design... Learn More

RESEARCH TRIANGLE PARK, NC – (October 17, 2022) – PhenX Toolkit will present two posters at the American Society of Human Genetics (ASHG) annual meeting at the Los Angeles Convention Center Wednesday, Oct. 26, from 3 to 4:45 p.m.   ... Learn More

RESEARCH TRIANGLE PARK, NC – (October 17, 2022) – PhenX Toolkit will host a workshop, “Using the PhenX Toolkit to design studies optimized for data sharing,” at the American Society of Human Genetics (ASHG) annual meeting on Friday, Oct. 28, from 12:30 to 1:30 p.m. in Conference Room 306 at... Learn More

Pioneering scientists at VIB, the University of Copenhagen, DKFZ, and Stanford University are the first to deploy systems that deliver highest-resolution view of subcellular gene expression activity MONHEIM AM RHEIN, Germany – June 7, 2022 – Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the launch of its... Learn More

Lausanne, Switzerland, July 12, 2022 - Saphetor, a global precision medicine company and the creator of VarSome, The Human Genomics Community and variant interpretation platform, announced today a partnership with PTC Therapeutics International Limited. The open genomics community, VarSome.com, brings together a vast global network of clinical and research genetic laboratories leveraging its industry-leading... Learn More

RIYADH, Kingdom of Saudi Arabia--King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics programs. The integration aligns with Saudi Arabia’s Vision 2030 to strengthen the Kingdom’s healthcare sector and its services with technological... Learn More

Are you interested in reducing the evironmental impact of research or does your instition have climate and sustainbility goals? Let us help you achieve them by creating a closed loop economy of laboratory consumables and engaging in plastic recycling.  Here at Polycarbin, we provide our biopharma and... Learn More

Xenium In Situ technology will revolutionize our understanding of the diverse cellular landscape underlying developing, healthy, and diseased tissue. Single cell and spatial technology transformed our ability to discover rare biology. Now, Xenium lets you explore the cellular locations of hundreds of targets and fully immerse yourself in the diversity of... Learn More

HELSINKI, Finland, August 2021. Finnish bioinformatics software company Euformatics has been awarded funding through the Amazon Web Services (AWS) Diagnostic Development Initiative to deliver a revolutionary COVID-19 variant surveillance software tool. SYNLAB has agreed to be the first customer of the solution developed under the program. The funding also covers broader deployment... Learn More

HELSINKI, Finland, May 2022. Euformatics, BC Platforms and Oncompass Medicine formed a partnership to bid for the development of standardized oncology workflows for a buyer consortium of seven leading hospitals* based in Central Europe and co-funded by the European Union Grant Agreement n° 874719. The buyer consortium, represented by the Medical University... Learn More

ESPOO, Finland, July 1st 2022. Finnish bioinformatics software company Euformatics has been awarded a grant from the European Commission’s Recovery and Resilience Facility to study, research and develop advanced software algorithms and workflows for clinical diagnostics of cancer and rare diseases. The funding also covers the development of an interlaboratory quality... Learn More

Toronto, Ontario: Gene42, a leading provider of precision medicine software for hospitals such as SickKids, Stanford Children’s Health, and Great Ormond Street, today announced the launch of its new brand identity as PhenoTips®. This rebranding marks a milestone for the company, accompanying a rapidly expanding client base and recent doubling of... Learn More

Toronto, Ontario: PhenoTips®, the first precision medicine software company to offer a complete genomic health record™ system, has announced their graduation from the 2019-2020 Health stream of the Creative Destruction Lab (CDL) program, a startup accelerator hosted by the University of Toronto’s Rotman School of Management. Developed out... Learn More

Toronto, Ontario: PhenoTips, creator of the world’s first complete Genomic Health Record™, has launched a digital tool that automatically generates pedigrees from patient-entered information. Pre-Visit Patient Questionnaires are delivered virtually to patients, building pedigrees and patient records in advance of a patient’s initial consultation, which improves... Learn More

Toronto, Canada, September 21, 2021 – Genetics software startup PhenoTips® announced today that it has raised CAD $2.5 million in an oversubscribed seed fundraising round led by the GreenSky Accelerator Fund IV. This round includes the support of the Toronto Innovation Acceleration Partners, Thin Air Labs,... Learn More

Toronto, Ontario: PhenoTips, producer of the leading software solution for medical genetics, is proud to announce the pledge of 1% of their equity to the Upside Foundation of Canada in support of CHEO Foundation, SickKids Foundation, and the Canadian Organization for Rare Disorders (CORD). The Upside Foundation of Canada is a registered Canadian... Learn More

Leading genomics solutions provider debuts complete NGS library preparation to support the identification of novel monkeypox variants in response to growing researcher demands for viral surveillance solutions CORALVILLE, Iowa — (August 30, 2022) — With the World Health Organization declaring the monkeypox virus... Learn More

With more than 35,000 combinations tested, IDT delivers unique master mix with proprietary blend to enrich endpoint fluorescence, optimize data confidence CORALVILLE, Iowa — (Sept. 26, 2022) — To support the growing need for an inhibitor resistant, high-performance master mix that allows for... Learn More

Gencove Raises $10 Million to Meet the Global Demand for Accessible and Interpretable Whole Genome Sequencing at Scale The company’s low-pass genome sequencing and bioinformatics platform provides a new way to power complete, accurate, and affordable genomic discovery ... Learn More

Gencove and Element Biosciences, Inc. Partner to Offer Low-Pass Whole Genome Sequencing and Analysis with the AVITI™ System The Agreement Expands Options for Customers Seeking Cost-Effective, High-Throughput Whole Genome Sequencing NEW YORK – Gencove, pioneer of low-pass whole... Learn More

BGI and Gencove Extend Agreement to Offer Low-Pass Whole Genome Sequencing and Analysis Services to Advance Global Health and Sustainability Partnership delivers high-volume, cost-efficient, low-pass whole genome sequencing for human genetics and other applications. NEW YORK... Learn More

Hayward, CA – March 7, 2022 – Mawi DNA Technologies (Mawi), a leader in biosample collection technologies, announces the company received CE Mark and UK MHRA approval for its portfolio of iSWAB non-invasive collection devices. This approval includes Mawi’s HemaSure-OMICS whole blood collection tubes for gDNA, cfDNA, and RNA from... Learn More

Hayward, CA - February 9, 2022 – Mawi DNA Technologies (Mawi), a leading biosampling collection company, announces it has been awarded the ISO 9001:2015 Quality Management Systems and ISO 13485:2016 Medical Devices Quality Management Systems certifications. Mawi developed and commercialized the iSWAB technology, an innovative system for collection of biosamples.... Learn More

Dr. El-Fahmawi channels years of varied experience into his work with Mawi DNA Technologies HAYWARD, CA, July 7, 2022, Dr. Bassam El-Fahmawi has been included in Marquis Who’s Who. As in all Marquis... Learn More

Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with ProteographTM Analysis Suite 2.0 Scalable, high-resolution, sample-specific analysis brings genomics and proteomics together to enable novel biological insights with the click of a button ... Learn More

Clinical Genetics Information at Your Fingertips NCBI has medical genetics resources to help you research, detect, and treat diseases and conditions. You can easily access our data and tools through the Medical Genetics and Human Variation page of the NCBI website. We also encourage you to join... Learn More

The National Institutes of Health (NIH) Comparative Genomics Resource, known as CGR, is a multi-year National Library of Medicine project to maximize the impact of eukaryotic research organisms and their genomic data resources to biomedical research. The National Center for Biotechnology Information (NCBI) is charged with leading development and engaging... Learn More

Carlsbad, Calif. – September 20, 2022—Arima Genomics, Inc., the leader in 3D genomics, today announced that it has moved its headquarters to the Arroyo Business Center complex in Carlsbad, California. The 11,000+ square foot headquarters located at 6354 Corte Del Abeto, Suite B, includes six laboratories, enabling the company to... Learn More

New Library Prep Module provides a robust addition to Arima’s well-established Hi-C workflows. San Diego, Calif. – June 07, 2022—Arima Genomics, Inc., the leader in 3D genomics, today announced the launch... Learn More

Generate the most comprehensive genome assemblies with Arima Hi-C technology with our Genome Assembly Grant. Improve draft assemblies, assign and orient contigs, and build chromosome-scale assemblies to empower your research. Great genome biology is built on a foundation of high-quality, phased, chromosome-scale genome assemblies.... Learn More

Collaboration Integrates DNAnexus’ Proven Biomedical Data Analysis Platform With Twist’s NGS Methylation Detection And Unique Molecular Identifier Adapter Systems   MOUNTAIN VIEW, Calif. and SOUTH SAN FRANCISCO, Calif. — July 13, 2022 — DNAnexus, Inc., a leading provider of cloud-based biomedical data... Learn More

MOUNTAIN VIEW, Calif. — March 08, 2022 — DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical... Learn More

28 September 2021 – UK Biobank, a large-scale biomedical database and research resource, announces today the launch of a uniquely powerful and innovative research platform that allows approved researchers to access and analyse the entire UK Biobank database securely, in the cloud, from anywhere in the world. It is designed... Learn More

Our Future Health’s trusted research environment will collect information from millions of volunteers and provide tools to transform the prevention, detection, and treatment of diseases MOUNTAIN VIEW, Calif. — Sept 12th, 2022 — Learn More

MINNEAPOLIS, July 5, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH), today announced it has completed the acquisition of Namocell, Inc. The Namocell acquisition adds easy-to-use single cell sorting and dispensing platforms that are gentle to cells and preserve cell viability and integrity. Namocell’s instruments and consumables are critical... Learn More

3billion announced that they will be looking to sponsor a large-scale research project for rare disease diagnosis research. Unlike previous research collaborations, the Mega GRANT program will provide over 500 WES services for a single research project.    3billion is helping those... Learn More

You Kyung Cho, a Research Scientist at 3billion's bioinformatics and web development teams will present SpliceVi at ASHG 2022. SpliceVi is a software that predicts cryptic splicing sites (CSS) and consequences.    SpliceAI, a software developed and distributed by Illumina, has limits,... Learn More

Kisang Kwon, a Research Scientist at 3billion's Bioinformatics team will present methods to improve the accuracy of variant classification when diagnosing rare disease patients from underrepresented populations at ASHG 2022.    One of the most important pieces of information used to categorize... Learn More

Dr. Kyoung-yeol Lee, leader of 3billon's artificial intelligence (AI) team,  will present his  AI model for rare disease diagnosis at ASHG 2022.   Dr. Lee's AI team was recently chosen as the top performing team from the Critical Assessment of Genome Interpretation... Learn More

3billion will participate in the American Society of Human Genetics (ASHG) Annual Conference, 24 to 28 October, for five days in Los Angeles, United States of America.    The ASHG Annual Conference is the world's largest human genetics and genomics academic conference,... Learn More

Chromosome analysis is a routine method of cytogenetics and has been considered the "Gold Standard" in genetic diagnostics for decades. Despite the widespread use of digital imaging systems such as MetaSystems' Ikaros karyotyping software, the process of preparing a karyogram has remained a highly interactive procedure. This is contrasted with steadily increasing... Learn More

NGS workflow solutions enable scientists to focus on more valuable tasks such as interpreting data and making discoveries Genomics is the study of the library of genes for a given organism. A genome is an organism's complete set of genetic instructions. From a genome comes the expression... Learn More

Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data SANTA CLARA, Calif., June 07, 2022 Agilent Technologies Inc. (NYSE: A), a global leader in genomics technology, today... Learn More

The Danish National Genome Center has teamed up with the UK firm Lifebit to improve the access and sharing of genomic data as the nation moves towards the adoption of personalized medicine.   Personalized medicine is capturing the attention of healthcare authorities across the world. By harvesting genome... Learn More

Finding routes to novel therapeutics requires large amounts of genomic data. But efforts to collect and use these data are often hampered by the need to guarantee a high level of data security, making it difficult to pool information from biobanks across the world. Lifebit, a London-based software firm, has... Learn More

  The partnership among three research and data specialists is aimed at creating a global database to support faster development of novel cancer treatments.   UK-based Lifebit, Genomics England, and NIHR Cambridge are joining forces on an ambitious project: creating the largest cancer database on the planet.... Learn More

Thorben Seeger, Chief Business Development Officer at UK-based precision medicine software company Lifebit, wants to democratize the data held by the world’s leading genomic institutions. But who exactly is partnering with Lifebit? What does the word “democratize” mean here? And, more importantly still, how can pharma and bioscience benefit? Here’s... Learn More

Lifebit Counting on New UK Partnerships to Develop, Validate Federated Data Model Feb 08, 2022 | Neil Versel   CHICAGO – With the help of a short-term UK government grant and a long-term partnership with a research institute, Lifebit Biotech hopes to make federated sharing of genomic... Learn More

May 03, 2022: https://www.businesswire.com/news/home/20220503005572/en/... Learn More

December 06, 2021: https://www.businesswire.com/news/home/20211206005146/en/... Learn More

May 06, 2021: https://www.businesswire.com/news/home/20210506005076/en/  ... Learn More

23 May, 2022 Collaborative initiative leverages CENTOGENE’s differentiated diagnostic expertise with testing performed in over 650,000 individuals globally Recommendations provide standardized clinical application guidelines for laboratories to accelerate comprehensive diagnosis and promote better health outcomes WGS... Learn More

13 Jun, 2022 Working together on the world’s first treatment that targets the underlying causes of pyruvate kinase (“PK”) deficiency in children under the age of 18 Expanded collaboration to include Phase 3 ACTIVATE-kids and ACTIVATE-kidsT studies... Learn More

Newly released Evercode™ Whole Transcriptome v2 kits have demonstrably improved gene detection and robustness. SEATTLE, August 30, 2022 –  Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a significant performance update of its chemistry for the Evercode™ Whole Transcriptome products.  ... Learn More

Watertown, MA., May 5, 2022 – Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, announced expanded early access to two new products for 3′ single-cell RNA analysis. Scaled to efficiently and effectively meet diverse experimental demands, PIPseqTM T2 and T20 kits capture up to... Learn More

Watertown, MA, June 17, 2022 – Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, and NanoCellect Biomedical, Inc., a leader in the development and manufacturing of innovative and affordable solutions for cell sorting, jointly announced a collaboration to improve resolution and efficiency... Learn More

Priced as low as $300 per reaction, the T2 and T20 kits enable any researcher to immediately access the power of single-cell transcriptomics with no capital investment WATERTOWN, Mass., June 23, 2022 /PRNewswire/ — Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, announced... Learn More

INDIANAPOLIS — (November 22, 2021) — Chemistry companies continue seeking partnerships with Beckman Coulter Life Sciences ahead of the 2022 launch of the Biomek NGeniuS Next Generation Library Preparation System. Today, Beckman Coulter Life Sciences announced a second application development agreement for the instrument. This latest partnership enables... Learn More

INDIANAPOLIS – (February 16, 2022) – Beckman Coulter Life Sciences continues to work with chemistry companies seeking collaborations to develop applications for the Biomek NGeniuS Next Generation Library Preparation System ahead of its launch. An application development agreement has been signed with Illumina, a developer of solutions for the sequencing and... Learn More

Errors, Hands-On-Time Reduced Through Powerful Automation Features Indianapolis, IN – (June 28, 2022) Beckman Coulter Life Sciences, a global leader in laboratory workflow automation and innovation, and a company of Danaher Corporation (NYSE: DHR), unleashes the power of next generation sequencing and makes it more accessible for research... Learn More

Boulder, CO, June 2, 2022 – Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA, today announced it had secured $40 million in an oversubscribed Series A, bringing total funding to date to $53.5 million. The... Learn More

DeNovix Inc, a developer and manufacturer of instrumentation and assays for the life sciences, has been awarded the prestigious Customer Service Company of the Year at the SelectScience Scientists’ Choice Awards for Life Science. The presentation was made at a ceremony held during the recent AACR (American Society for Cancer... Learn More

DeNovix Inc., a developer and manufacturer of instrumentation and assays for the life sciences, introduces a new RNA fluorescence quantification assay. The assay is suitable for multiple platforms including stand-alone fluorometers, plate readers or any DeNovix fluorescence based instrument. The new DeNovix RNA Assay delivers a greater... Learn More

DeNovix has become the first company to receive a second Platinum Seal of Quality for life science instrumentation. The CellDrop Automated Cell Counter follows the DS-11 Series Spectrophotometer / Fluorometer in receiving the top award based on the reviews of scientists from around the globe. “CellDrop winning... Learn More

ROCKVILLE, Md. — November 11, 2021 —  Learn More

ROCKVILLE, MD — April 13 2021 —  Learn More

New Collaborations Will Accelerate the Impact of Multiomics on Human Health

Learn More